Granules India Ltd.

Financial

	Granules India	Solara Active Pharma	IOL Chem & Pharma
Operational Metrics
API Sector
US DMF Filings	39.0 .	230.0 .	n/a
Europe DMF Filings	5.0 .	n/a	n/a
Manufacturing Capacity - Metformin	2000.0 MTPA	n/a	7200.0 MTPA
Manufacturing Capacity - Ibuprofen	4800.0 MTPA	5000.0 MTPA	12000.0 MTPA
Total reactor capacity	456.5 kL	n/a	n/a
Pharmaceutical Sector
Manufacturing Capacity - Paracetamol	34560.0 MTPA	n/a	3600.0 MTPA
Number of ANDA's Approved By USFDA	68.0 .	n/a	n/a
Number of ANDA's Filed in USA	83.0 .	n/a	n/a
Number of ANDA's Filed	119.0 .	n/a	n/a
Number of ANDA's Approved	92.0 .	n/a	n/a
R&D as a % of Total Sales	3.15 %	n/a	0.91 %
Financials
5 yr Average ROE	18.04 %	-8.31 %	9.87 %
5yr average Equity Multiplier	1.73	1.98	1.41
5yr Average Asset Turnover Ratio	0.85	0.55	1.03
5yr Avg Net Profit Margin	12.26 %	-5.56 %	6.75 %
Price to Book	4.04	2.37	1.3
P/E	28.9	0.0	21.64
5yr Avg Cash Conversion Cycle	39.26 Days	115.03 Days	45.42 Days
Inventory Days	75.67 Days	106.31 Days	64.41 Days
Days Receivable	78.34 Days	125.38 Days	83.56 Days
Days Payable	115.94 Days	142.19 Days	94.27 Days
5yr Average Interest Coverage Ratio	18.0	0.55	17.62
5yr Avg ROCE	22.1 %	3.01 %	13.96 %
5yr Avg Operating Profit Margin	21.01 %	10.34 %	10.94 %
5 yr average Debt to Equity	0.41	0.69	0.03
5yr CAGR Net Profit	3.86 %	n/a	-4.32 %
5yr Average Return on Assets	10.46 %	-2.61 %	6.97 %
Shareholdings
Promoter Holding	38.85 %	37.23 %	52.62 %
Share Pledged by Promoters	0.0	40.74 %	0.0
Change in Promoter Holding (3 Yrs)	-3.13 %	-2.28 %	8.93 %
Change in Mutual Fund Holding (3 Yrs)	6.26 %	-3.57 %	-0.48 %

Business

	Granules India	Solara Active Pharma	IOL Chem & Pharma
Product Wise Break-Up	Product Wise Break-Up Paracetamol 46.0 Metformin 22.0 Ibuprofen 10.0 GGF 4.0 MCB 3.0 Ibuprofen 0 Active Pharmaceutical Ingredients (API) 0 API 0 Chemicals 0 Ethyl Acetate 0 Pantaprazole 0 Clopidogrel 0 Metformin 0 Others 15.0	Product Wise Break-Up Chemicals 0 Pantaprazole 0 Paracetamol 0 Active Pharmaceutical Ingredient (API) 100.0 Ethyl Acetate 0 GGF 0 MCB 0 Clopidogrel 0 Ibuprofen 0 Metformin 0 API 0	Product Wise Break-Up Chemicals 43.0 Pantaprazole 0 Paracetamol 0 Active Pharmaceutical Ingredients (API) 0 Ethyl Acetate 0 GGF 0 MCB 0 Clopidogrel 0 Ibuprofen 37.0 Metformin 0 API 20.0
Segment Break-Up	Segment Break-Up Formulations 77.0 Active Pharmaceutical Ingredient (API) 15.0 PFI 8.0 0 Pharmaceuticals 0	-	Segment Break-Up Formulations 0 Active Pharmaceutical Ingredient (API) 0 Pharmaceutical 50.27 Chemicals 48.63 PFI 0 Others 1.1
Location Wise Break-Up	Location Wise Break-Up USA 79.0 Europe 10.0 Rest of the World 5.0 Latin America 4.0 India 2.0 Canada 0 AMEA 0 South America 0 North America 0 Asia Pacific 0	Location Wise Break-Up Europe 23.03 India 0 USA 0 South America 0.45 Canada 0 Rest of the World 0 Latin America 0 North America 6.76 Asia Pacific 55.91 AMEA 0 Others 13.85	Location Wise Break-Up Europe 0 India 71.69 USA 0 South America 0 Canada 0 Rest of the World 28.3 Latin America 0 North America 0 Asia Pacific 0 AMEA 0 Others 0.01

Granules India Ltd.

SIGN UP FOR FREE